SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-340859
Filing Date
2018-12-03
Accepted
2018-12-03 13:53:05
Documents
7
Period of Report
2018-11-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d666688d8k.htm 8-K 22793
2 EX-4.1 d666688dex41.htm EX-4.1 89973
3 EX-4.2 d666688dex42.htm EX-4.2 85892
4 EX-5.1 d666688dex51.htm EX-5.1 12792
5 EX-10.1 d666688dex101.htm EX-10.1 183563
6 EX-99.1 d666688dex991.htm EX-99.1 9317
7 GRAPHIC g666688g71m63.jpg GRAPHIC 7767
  Complete submission text file 0001193125-18-340859.txt   416493
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 181213629
SIC: 2834 Pharmaceutical Preparations